Regeneron halts trial of antibody treatment in seriously ill Covid patients - Financial Times
- Regeneron halts trial of antibody treatment in seriously ill Covid patients Financial Times
- Study finds brain abnormalities 'common' in COVID-19 patients Yahoo Lifestyle
- Study finds 20 percent of grocery workers had COVID-19, most without symptoms New York Post
- Two coronavirus side effects that might never go away BGR
- COVID toes update: Analysis finds symptoms could last months TODAY
- View Full Coverage on Google News